NextCure, Inc. SEC filings NXTC

NextCure, Inc. has 394 filings in SEC EDGAR's recent list, going back to Jan 11, 2016. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.

NextCure, Inc. SEC filings
Form Description Filed Period
S-4/A Filing Nov 2, 2026 —
8-K Current report
Officer or director change
Oct 30, 2026 Oct 26, 2026
S-4/A Filing Oct 1, 2026 —
425 Filing Sep 25, 2026 —
8-K Current report
Other events
Sep 25, 2026 Sep 21, 2026
8-K Current report
Material agreement
Sep 3, 2026 Sep 3, 2026
S-4 Registration for a merger or exchange Aug 18, 2026 —
425 Filing Aug 10, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
425 Filing Aug 4, 2026 —
425 Filing Jul 16, 2026 —
425 Filing Jul 14, 2026 —
8-K Current report
Material agreement, Exit or restructuring costs, Change in control, Officer or director change, Regulation FD disclosure, Other events
Jul 14, 2026 Jul 14, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 25, 2026 Jun 18, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 1, 2026 Jun 1, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 18, 2026
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 23, 2026 Jan 23, 2026
8-K Current report
Other events
Dec 19, 2025 Dec 19, 2025
424B5 Prospectus supplement Dec 19, 2025 —
EFFECT Filing Dec 11, 2025 —
424B1 Filing Dec 11, 2025 —
D Filing Dec 10, 2025 —
CORRESP Letter to the SEC Dec 9, 2025 —
S-3 Shelf registration Nov 26, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Nov 17, 2025 Nov 12, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Officer or director change
Aug 25, 2025 Aug 21, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
EFFECT Filing Jul 29, 2025 —
424B2 Prospectus Jul 29, 2025 —
CORRESP Letter to the SEC Jul 28, 2025 —
UPLOAD Letter from the SEC Jul 24, 2025 —
S-3 Shelf registration Jul 18, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jul 14, 2025 Jul 14, 2025
8-K Current report
Other events
Jul 10, 2025 Jul 10, 2025
8-K Current report
Shareholder vote results
Jun 23, 2025 Jun 20, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jun 16, 2025 Jun 13, 2025
DEFA14A Additional proxy material May 19, 2025 —
DEFA14A Additional proxy material May 19, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 20, 2025
PRE 14A Preliminary proxy statement Apr 15, 2025 Jun 20, 2025
8-K Current report
Regulation FD disclosure
Apr 10, 2025 Apr 10, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
8-K Current report
Listing notice
Feb 3, 2025 Jan 31, 2025
8-K Current report
Other events
Jan 10, 2025 Jan 10, 2025
8-K Current report
Other events
Dec 10, 2024 Dec 10, 2024
8-K Current report
Regulation FD disclosure
Dec 5, 2024 Dec 5, 2024
8-K Current report
Regulation FD disclosure
Nov 8, 2024 Nov 8, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 20, 2024
8-K Current report
Officer or director change
Jun 18, 2024 Jun 18, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 20, 2024
PRE 14A Preliminary proxy statement Apr 16, 2024 Jun 20, 2024
10-K Annual report Mar 21, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 21, 2024 Mar 21, 2024
8-K Current report
Regulation FD disclosure
Dec 14, 2023 Dec 14, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
EFFECT Filing Aug 11, 2023 —
CORRESP Letter to the SEC Aug 9, 2023 —
UPLOAD Letter from the SEC Aug 8, 2023 —
S-8 Employee stock plan registration Aug 4, 2023 —
S-3 Shelf registration Aug 4, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Officer or director change
Jul 19, 2023 Jul 15, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 26, 2023 Jun 22, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 22, 2023
424B5 Prospectus supplement Apr 4, 2023 —
10-K Annual report Mar 2, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 2, 2023 Mar 2, 2023
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Shareholder vote results
Jun 23, 2022 Jun 23, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 23, 2022
10-K Annual report Mar 3, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Mar 3, 2022 Mar 3, 2022
8-K Current report
Regulation FD disclosure
Nov 15, 2021 Nov 13, 2021
S-8 Employee stock plan registration Nov 4, 2021 —
S-8 Employee stock plan registration Nov 4, 2021 —
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 4, 2021 Oct 1, 2021
8-K Current report
Officer or director change
Sep 24, 2021 Sep 21, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Shareholder vote results
Jun 25, 2021 Jun 24, 2021
8-K Current report
Other events
May 6, 2021 May 6, 2021
424B5 Prospectus supplement May 6, 2021 —
10-Q Quarterly report May 6, 2021 Mar 31, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 29, 2021 Jun 24, 2021
UPLOAD Letter from the SEC Apr 29, 2021 —
CORRESP Letter to the SEC Apr 26, 2021 —
10-K/A Amended annual report Apr 26, 2021 Dec 31, 2020
UPLOAD Letter from the SEC Apr 15, 2021 —
EFFECT Filing Mar 12, 2021 —
POS AM Filing Mar 5, 2021 —
10-K Annual report Mar 4, 2021 Dec 31, 2020
POSASR Filing Mar 4, 2021 —
8-K Current report
Results of operations
Mar 4, 2021 Mar 4, 2021
8-K Current report
Officer or director change
Feb 24, 2021 Feb 21, 2021
8-K Current report
Regulation FD disclosure
Jan 14, 2021 Jan 14, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 14, 2020 Sep 10, 2020
S-3ASR Automatic shelf registration Aug 6, 2020 —
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Officer or director change
Jul 31, 2020 Jul 27, 2020
8-K Current report
Officer or director change
Jul 17, 2020 Jul 14, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 13, 2020 Jul 8, 2020
8-K Current report
Shareholder vote results
Jun 11, 2020 Jun 11, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 27, 2020 —
DEF 14A Proxy statement Apr 27, 2020 Jun 11, 2020
8-K Current report
Regulation FD disclosure
Apr 14, 2020 Apr 13, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 30, 2020 Mar 25, 2020
10-K Annual report Mar 12, 2020 Dec 31, 2019
SEC STAFF LETTER Filing Feb 19, 2020 —
SEC STAFF LETTER Filing Feb 10, 2020 —
8-K Current report
Agreement ended
Jan 13, 2020 Jan 10, 2020
8-K Current report
Other events
Dec 2, 2019 Dec 2, 2019
424B4 Prospectus Nov 18, 2019 —
EFFECT Filing Nov 14, 2019 —
S-1MEF Filing Nov 14, 2019 —
S-1/A Amended registration statement Nov 14, 2019 —
CORRESP Letter to the SEC Nov 12, 2019 —
CORRESP Letter to the SEC Nov 12, 2019 —
S-1 Registration statement Nov 12, 2019 —
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
UPLOAD Letter from the SEC Nov 6, 2019 —
DRS Filing Oct 30, 2019 —
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 2, 2019 Oct 2, 2019
10-Q Quarterly report Aug 12, 2019 Jun 30, 2019
8-K Current report
Regulation FD disclosure
Aug 9, 2019 Aug 8, 2019
10-Q Quarterly report Jun 10, 2019 Mar 31, 2019
S-8 Employee stock plan registration May 13, 2019 —
S-8 Employee stock plan registration May 13, 2019 —
8-K Current report
Bylaw or fiscal year change, Other events
May 13, 2019 May 13, 2019
424B4 Prospectus May 9, 2019 —
EFFECT Filing May 8, 2019 —
S-1/A Amended registration statement May 8, 2019 —
CERT Filing May 8, 2019 —
8-A12B Filing May 8, 2019 —
SEC STAFF LETTER Filing May 7, 2019 —
CORRESP Letter to the SEC May 6, 2019 —
S-1/A Amended registration statement May 3, 2019 —
SEC STAFF LETTER Filing Apr 29, 2019 —
S-1/A Amended registration statement Apr 29, 2019 —
CORRESP Letter to the SEC Apr 17, 2019 —
S-1 Registration statement Apr 12, 2019 —
DRSLTR Filing Apr 1, 2019 —
DRS/A Filing Apr 1, 2019 —
UPLOAD Letter from the SEC Mar 13, 2019 —
DRSLTR Filing Mar 5, 2019 —
DRS/A Filing Mar 5, 2019 —
UPLOAD Letter from the SEC Feb 25, 2019 —
DRSLTR Filing Jan 30, 2019 —
DRS Filing Jan 30, 2019 —
D Filing Nov 19, 2018 —
D Filing Jan 11, 2016 —

Showing 187 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NXTC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Baltimore, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1661059

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.